Chapter 30: Protein Synthesis Inhibitors

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to another deep dive from the Last Minute Lecture team.

I'm really excited about this one because we're basically talking about cellular sabotage.

Yeah, that is honestly the if you're a college student staring down your first pharmacology exam, you know the drill.

Today, our mission is to conquer Chapter 30 of Lippincott Illustrated Reviews,

Pharmacology.

We're looking at protein synthesis inhibitors.

Which sounds incredibly dense, I know, but it's actually a fascinating strategy.

It really is.

If you want to shut down a hostile factory, you don't need to blow up the entire building.

You just walk onto the factory floor and jam the machines inside.

Exactly, and for a bacterial cell, those vital machines are the ribosomes, the little engines that make all the proteins.

Right, so today we are mapping out how we jam, corrupt, and just completely dismantle those bacterial factories.

But before we get into the specific drugs, we need to talk about the core rule here, which is the selectivity principle.

Right, the selectivity principle.

This is the holy grail of pharmacology because, you know, you want to sabotage the bacterial factory, but you really, really don't want to destroy the human host's factory at the same time.

Yeah, collateral damage is bad.

Exactly, so we have to exploit these tiny structural differences.

Human ribosomes are built out of a 40S and a 60S subunit.

They combine to make an 80S ribosome.

Okay, 40 plus 60 makes 80.

I know the math is weird, but we just roll with it.

Yeah, it's based on sedimentation rates, not simple addition.

But anyway, bacterial ribosomes are built slightly differently.

They use a 30S and a 50S subunit to form a 70S ribosome.

So humans are 80S, bacteria are 70S.

Right, and that tiny variance is our therapeutic window.

We can engineer drugs that perfectly lock into the 30S or 50S bacterial pieces, but they just like slide right off our own 40S and 60S machinery.

Okay, but wait, if the whole rule is that we have completely different ribosomes, why do the sources say these drugs can sometimes be highly toxic to our cells?

If the key doesn't fit the lock, there shouldn't be any damage.

It does seem like a massive contradiction, doesn't it?

Yeah, it really does.

Well, it is a contradiction until you look at evolutionary history, specifically human mitochondria.

Oh, the powerhouse of the cell.

The powerhouse of the cell, exactly.

But millions of years ago, mitochondria were basically free living ancient bacteria that got swallowed up by our early cells.

Wait, really?

Yeah,

and because of that ancient lineage, human mitochondria still have ribosomes that look suspiciously like bacterial ribosomes.

Oh, wow.

So they're like molecular fossils.

Essentially, yes.

So when you push the doses of certain antibiotics too high, the drugs cross over and start binding to your own mitochondrial ribosomes.

You accidentally sabotage your own energy production.

That is wild.

Our evolutionary history actually dictates our drug side effects today.

It really does.

It's crazy mitochondrial exception in mind.

Let's start tearing down the factory.

The book starts with the 30S subunit, right?

Yep, the 30S saboteurs.

And the classic examples here are the tetracyclines.

Like doxycycline and minocycline.

Exactly.

So these drugs diffuse into the bacterial cell and bind reversibly to the 30S subunit.

And their mechanism is entirely physical.

The book actually has a great visual for this, figure 30 .2.

If you picture the ribosome as a loading dock, the messenger RNA is the instruction manual.

And you have these delivery trucks, the transfer RNAs or tRNAs, constantly trying to bring fresh amino acids to the dock.

Right, to build a protein chain.

So tetracyclines essentially act like a bouncer at the loading dock.

They just physically stand there and block the tRNA delivery truck from ever docking.

Which is such a great analogy.

And because they are just blocking the delivery, they are bacteriostatic.

Meaning they don't actually kill the bacteria.

Right.

They don't outright kill it.

They just hit pause on the factory line and stops the bacteria from multiplying, which buys your immune system the time it needs to swoop in and clear the infection.

Makes sense.

And they have a huge spectrum, right?

Figure 30 .3 lists a bunch.

Lime disease, cholera, chlamydia, Rocky Mountain spotted fever, even severe acne.

They're incredibly versatile, but you know, bacteria are highly adaptable.

If you try to And the main work around here is the efflux pump, right?

Yeah, the efflux pump.

The bacteria genetically adapt to build these microscopic vacuum pumps right into their cell membranes.

So as soon as the drug comes in?

The pump just grabs it and spits it right back out.

Yep.

The tetracycline can never reach the concentration it needs to block the 30S dock.

That is so frustrating.

Which actually brings us to the logistics of taking the drug, pharmacokinetics.

There's this graph, figure 30 .5, that is super important.

Oh, the milk graph.

The milk graph.

Yeah, it shows a patient's plasma levels of tetracycline.

If you take it on an empty stomach, you get a huge spike in absorption.

But if you take it with a glass of milk, the absorption completely flatlines.

It barely enters the blood at all.

Why is that?

It's due to a chemical process called chelation.

Tetracyclines have this very high affinity for metals, specifically divalent and trivalent medications.

So like calcium, magnesium, iron.

Exactly.

Milk is packed with calcium.

Over -the -counter antacids are packed with magnesium.

When the drug meets those metals in your stomach, they bind tightly together and form a heavy, non -absorbable chelate complex.

So the molecule just becomes too bulky to cross the intestinal wall.

Right.

Your body can't absorb it, so it just passes right through as waste.

So the rule is strictly an empty stomach.

But the crazy thing is, that exact same calcium binding property is the reason behind their most famous side effect.

Yes, the bone and teeth issues.

Because if tetracyclines eagerly bind to calcium in your stomach, they will just as eagerly bind to calcium in your body.

Oh, yikes.

Yeah.

If you give this to a pregnant patient or a young child whose bones and primary teeth are actively calcifying, the drug deposits directly into that newly forming calcium matrix.

Which causes that permanent yellow or brown discoloration of the teeth.

And it can even temporarily stunt overall bone growth, which is why they are strictly contraindicated in pregnancy, breastfeeding, and in kids under eight years old.

You're literally staining their developing skeleton.

It's rough.

And the systemic effects go further too.

You see severe gastric irritation and a really specific phototoxicity.

Wait, phototoxicity?

Like sunburn?

Yeah, severe sunburn.

The drug actually deposits in the skin, absorbs UV light from the sun, and creates free radicals.

You can get blistering sunburns after just a few minutes outside.

That's terrifying.

And what about minocycline?

The texts single that one out for causing dizziness.

Menocycline is a bit of a quirk.

It is incredibly lipophilic, meaning it dissolves easily in fats.

So it rapidly crosses the blood -brain barrier and concentrates in the lipid -rich fluid of the inner ear.

Oh, so messes with your balance.

Exactly.

It disrupts the vestibular system, causing intense dizziness and vertigo.

Good to know.

Oh, and I want to make sure we mention doxycycline here.

Most of these drugs are cleared by the kidneys.

But if a patient has renal failure, doxycycline is the absolute go -to exception, right?

Right.

Doxycycline skips the kidneys almost entirely.

It's eliminated via the bile directly into the feces, so it's safe for renal patients.

Okay, so if bacteria are outsmarting tetracyclines with those microscopic bilge pumps, how do we fight back?

We basically out -engineer them.

Pharmacologists designed a structural counterattack called the glycylcyclins.

Enter tigacycline.

Exactly.

Tigacycline is just a synthetic derivative of minocycline.

They took the minocycline molecule and added this massive, bulky side chain to it.

So it still targets the 30S subunit perfectly, but it's just too fat for the efflux pump to grab.

That's exactly it.

It slips right past their primary defense mechanism.

Which makes it a heavy -hitter against multidrug -resistant bugs like MRSA and VRE, vancomycin -resistant n -erfococci, though the book mentions it's totally useless against pseudomonas.

Yeah, pseudomonas is notoriously tricky.

But the main thing to know about tigacycline is its kinetic profile.

It has a massive volume of distribution.

Meaning it leaves the bloodstream really quickly to penetrate deep into the tissues, right?

Right.

So clinically, if you're treating a complicated skin infection or a deep abdominal infection, tigacycline is fantastic because it floods those tissues.

But if you have bacteremia, a severe infection in the blood itself,

it's a terrible choice.

Exactly.

It won't stay in the blood long enough to clear the pathogen.

And the toxicity is pretty brutal, too.

The text highlights intense nausea, acute pancreatitis, and a literal boxed warning for increased all -cause mortality.

Yeah, the mortality risk means it is strictly a last -resort drug.

You do not use tigacycline lightly.

Okay, let's shift gears but stay on the 30S subunit.

If tetracyclines are just bouncers holding the door, what happens if a drug actually gets inside the machine and starts changing the settings?

Now we're talking about the aminoglycosides, drugs like gentemisin, tobramycin, and amicosin.

They also bind the 30S subunit, but their mechanism is way more destructive.

Very destructive.

They actually physically warp the shape of the ribosome.

So when the messenger RNA feeds through, the warped machine misreads the genetic code.

So instead of just pausing production, the bacteria frantically build a chain of completely incorrect junky amino acids.

Right, and these junk proteins get inserted into the bacterial cell membrane, which basically tears the cell apart from the inside out.

So unlike the tetracyclines, aminoglycosides are highly bactericidal.

They are lethal.

They are absolute killers.

But their entry into the cell is pretty fascinating.

They rely on an oxygen -dependent active transport system to cross the bacterial cell wall.

They literally need oxygen to be pulled inside.

Yep.

Because of this, they are incredibly effective against aerobic gram -negative bacteria, but they are entirely useless against anaerobes because anaerobes don't have that oxygen pump.

Okay, that makes perfect sense.

Now the dosing strategy for aminoglycosides is super interesting to me.

Usually with antibiotics, you want a slow, steady level in the blood.

But with these, the book talks about high dose, extended interval dosing.

Why hit them with one massive dose and then let it drop to zero?

It exploits two really unique pharmacological properties.

First is concentration -dependent killing.

Meaning the higher the peak, the better.

Exactly.

The higher the drug concentration gets above the minimum inhibitory concentration, or MIC,

the faster and more violently it kills the bacteria.

You want that massive spike.

And the second property?

The post -antibiotic effect, or PAE.

Even after the drug is totally filtered out of the blood and levels drop to zero,

the surviving bacteria are so structurally devastated by that initial hit that they are paralyzed for hours.

They can't replicate.

That's incredibly elegant.

You hit them hard, and the shockwave lasts all day.

Yeah.

But getting the drug into the blood is tricky, right?

Figure 30 .8 shows they are highly polar polycationic molecules.

Yeah.

They are extremely hydrophilic.

They love water and completely repel lipids.

And since human cell membranes are made of lipids, these water -loving molecules just bounce right off.

Exactly.

If you swallow a gentamicin pill, it will not absorb into the bloodstream.

It just passes entirely through your GI tract.

So for systemic infections, they have to be given IV.

They also can't cross the blood -brain barrier easily.

Right.

Terrible for CNS infections.

But there is one brilliant exception to this absorption problem, and that's neomycin.

Oh, right.

Because neomycin is way too toxic to be given IV, isn't it?

It is.

But surgeons actually use its inability to be absorbed as a weapon.

A patient will swallow neomycin right before colorectal surgery specifically to sterilize the gut bacteria.

Because they know the drug will just stay safely trapped in the gut.

That's clever.

But for the ones we do give IV, the toxicity is a massive hurdle.

It really is.

Since they are excreted completely unchanged by the kidneys, they accumulate heavily in the renal tubules.

This causes severe nephrotoxicity.

And the second threat is the ears, right?

Ototoxicity.

Yeah.

They accumulate in the endolymph of the inner ear.

And unlike the temporary dizziness from minocycline, aminoglycoside damage can cause profound, irreversible deafness.

Irreversible.

Wow.

Yes.

Permanent hearing loss and balance issues, which is exactly why therapeutic drug monitoring is absolutely mandatory.

You have to constantly draw blood to check their plasma levels.

Right.

You're threading a needle.

The peak has to be high enough for that concentration -dependent killing.

But the trough, the lowest point before the next dose, has to drop low enough so the kidneys and ears can wash the drug out and recover.

Okay.

So we've thoroughly jammed the 30S side of the factory.

What happens when we target the actual assembly line, the 50S subunit?

Now we're moving to the macrolides and ketolides.

Erythromycin, clarithromycin, and azithromycin.

So if the 30S is where the code is read, the 50S is where the protein chain is physically assembled.

And macrolides bind irreversibly to the 50S and inhibit translocation.

Right.

I picture this exactly like a factory conveyor belt.

The amino acids are getting linked together, but the macrolide wedges itself into the gears.

The belt just physically cannot move the chain forward.

The whole assembly line grinds to a halt.

Clinically, they're a fantastic alternative for patients with severe penicillin allergies, but they really shine against atypical pneumonias.

Like mycoplasma and lychinella.

Yep.

Because those bugs lack a standard cell wall, penicillins are useless.

And they often hide inside our own cells.

Macrolides can penetrate those cells and shut them down.

But the real complexity here is the drug interactions.

Figure 30 .14 has this crucial diagram of the liver.

Erythromycin and clarithromycin are notorious inhibitors of the cytochrome P450 system.

The P450 system is basically the liver's chemical incinerator.

It breaks down and clears out foreign substances, including almost every other medication a patient takes.

So what does inhibiting P450 actually mean for the patient?

It means if you give erythromycin, it chemically jams that incinerator.

The P450 enzymes stop working.

Suddenly, any other drugs the patient is on, statins, warfarin, antiepileptics, stop being metabolized.

They just pile up in the bloodstream.

Exactly.

They rapidly reach toxic, potentially fatal levels.

That is terrifying.

You prescribe an antibiotic for a cough, and a week later, the patient has massive internal bleeding because their warfarin levels skyrocketed.

It requires intense medication reconciliation.

And then there's the digoxin mystery, which is just a perfect example of the microbiome.

Yes, explain this, because this blew my mind.

Okay.

So heart failure patients often take digoxin.

In a normal gut, a specific species of natural bacteria constantly chews up and destroys a large portion of that digoxin before it can even be absorbed.

Okay.

When you take a macrolide, the antibiotic wipes out that helpful gut flora.

Without those bacteria running interference, 100 % of the digoxin is suddenly absorbed into the blood.

Triggering an accidental, life -threatening digoxin overdose?

Yeah.

Just from taking an antibiotic.

Right.

And speaking of the gut, macrolides have notorious GI side effects.

Erythromycin isn't just irritating the stomach.

The drug molecule actually mimics a human hormone called modulin.

Which stimulates smooth muscle contraction in the gut.

Violently.

It induces such rapid gastric emptying that gastroenterologists sometimes prescribe erythromycin just to force the stomach to move in patients with gastroparesis.

Wow.

And we also have to monitor for cholestatic jaundice and QTC prolongation, right?

Yes.

The cardiac warning is critical.

Macrolides can block potassium channels in the heart, delaying electrical repolarization.

It stretches out the QT interval on an EKG and can trigger fatal arrhythmias.

So with all these interactions and side effects, it makes total sense why erythromycin is the fan favorite.

Oh, absolutely.

Erythromycin's structure lets it completely bypass the P450 incinerator.

No enzyme inhibition means no massive list of drug interactions.

Plus it has that incredibly high volume of distribution.

It saturates the tissues and releases so slowly you only need a 3 -5 day dosing pack.

The classic Z -Pak.

Exactly.

Though it can still cause hearing loss at high doses, so you do have to be careful.

Good to know.

Okay, moving further down the 50S subunit, we hit some highly specialized drugs.

First up is fadaxomycin, which is a weird structural cousin to the macrolides.

It's a total rule breaker.

It doesn't actually target the ribosome at all.

It binds to the bacterial RNA polymerase enzyme.

So it basically burns the messenger RNA blueprints before they even get to the factory floor.

That's exactly it.

But its true superpower is that it has almost zero systemic absorption.

That's like neomycin.

Exactly like neomycin.

If you swallow a fadaxomycin tablet, it stays entirely trapped in the GI tract.

Which makes it the perfect localized sniper rifle against Clostridium difficile.

Because C.

diff is trapped in the gut,

causing all that severe inflammation.

So the drug just sweeps through, kills the C.

diff, and exits without exposing the rest of the body.

Spot on.

Next up is chloramphenicol.

This one binds tightly to the 50S subunit, specifically blocking the peptidyl transferase center.

The enzyme that stitches the amino acids together.

But wait, isn't this the drug that triggers the mitochondrial exception we talked about at the very beginning?

Yes.

This is the main culprit.

At high doses, chloramphenicol crosses over and binds to the 70S -like ribosomes inside human mitochondria, particularly in the bone marrow.

Oh no.

So it halts human red and white blood cell production.

Yes.

Dose -dependent bone marrow suppression.

And even more terrifying, it can trigger an unpredictable, often fatal aplastic anemia.

That's horrifying.

And what about gray baby syndrome?

The techs had a huge warning about that.

Yeah, that comes down to liver metabolism.

To clear chloramphenicol, the human liver has to attach a sugar molecule to it, a process called gluteronidation.

And neonates don't have fully developed gluteronidation enzymes yet, right?

Right.

So if you give this to a newborn, their liver simply cannot process it.

The unmetabolized drug builds up massively, poisons their mitochondria, and triggers severe cardiovascular collapse.

And the lack of oxygen literally turns the baby's skin gray.

Exactly.

Because of this extreme toxicity, chloramphenicol is pretty much a historical relic in many places.

It's reserved strictly for life -threatening scenarios where every other option has failed.

Makes total sense.

Wrapping up the specialized 50S drugs is clindamycin.

Binds to the same site as a macrolide's absolute champion against MRSA and anaerobic infections, but it has this dark ecological irony to it.

The iron irony, yes.

While it's incredibly effective at clearing out anaerobic infections, it is equally effective at violently wiping out the normal healthy anaerobic flora of your gut.

Creating a massive empty ecological niche.

Exactly.

And C.

diff, which is naturally resistant to clindamycin, just moves right into that empty real estate, rapidly overgrows and causes severe pseudomembranous colitis.

So the drug you use to cure a skin infection actively creates the exact C.

diff gut infection that we just learned fadaxomycin is designed to treat.

It is the circle of pharmacological life.

And, you know, if fadaxomycin isn't available, oral metronidazole or oral vancomycin become the go -to agents to suppress that clindamycin -induced overgrowth.

The factory wars just never end.

So when bacteria inevitably mutate their 50S receptors, or pump up their efflux pumps to survive all of this, what do we have left?

We deploy the final reserves.

These are the heavy artillery agents strictly reserved for highly resistant strains.

First is quinipristin and delphopristin.

This is a mixture of two streptogrammins, right?

In an exact 30 to 70 ratio.

Right.

Individually, they are just bacteriostatic.

But together, they act highly synergistically.

They bind to two completely separate sites on the 50S subunit.

So delphopristin warps the ribosome.

And that warping actually enhances the binding of quinipristin, which then forces the ribosome to prematurely eject the incomplete protein chain.

Hitting two spots at once makes it powerfully bactericidal.

Yes, but due to severe venous irritation and joint pain, it's pretty much restricted just to treating VRE.

Okay, the ultimate final reserve in the text is the oxazolidinone class, specifically linezolid.

Linezolid.

It binds to the 23S ribosomal RNA of the 50S subunit.

But instead of jamming the gears of an active factory, it prevents the factory from ever being built.

It stops the 50S and 30S subunits from ever merging together into the 70S complex.

That's brilliant.

But this one has a really strange interaction, right?

Something to do with cheese and antidepressants.

Yes.

It's so weird, but so important.

Linezolid has non -selective monoamine oxidase inhibitor, or MAOI activity.

Monoamine oxidase is the human enzyme that breaks down neurotransmitters like serotonin, as well as an amino acid called tiramine.

Tiramine is found in aged fermented foods, sharp cheeses, red wine, cured meats.

Right.

So if a patient on linezolid eats a charcuterie board, the drug blocks the enzyme that normally clears that tiramine.

The tiramine builds up and triggers a massive release of norepinephrine.

Leading to a dangerous hypertensive crisis.

Exactly.

And if they take linezolid with an SSRI antidepressant, the blocked enzyme causes serotonin levels in the brain to skyrocket, triggering serotonin syndrome.

High fever, tremors, seizures.

It's very dangerous.

And prolonged use beyond 28 days also risks mitochondrial toxicity, leading to irreversible peripheral neuropathies and optic neuritis, which can cause permanent blindness.

It really is heavy artillery.

Wow.

Okay, so stepping back, what does this all mean?

We started by looking at a bacterial cell as a complex manufacturing plant.

And the incredible logic of pharmacology is that by just identifying the tiny microscopic differences between our ADS ribosomes and their 70S ribosomes, we can engineer highly specific saboteurs.

Right.

But as we saw with the mitochondrial exception and the P450 incinerator,

understanding the ancient overlaps and shared metabolic pathways is what actually allows us to predict and manage those devastating side effects.

Exactly.

The human body is just so interconnected.

It is.

And the ultimate takeaway here is recognizing that this bacterial factory is never static.

Bacteria replicate by the billions every single hour.

And with every replication, their genetic blueprints undergo random mutations.

They're constantly altering the shape of their 30S and 50S subunits.

Or building new efflux pumps to bail out these exact drugs.

It is a literal evolutionary arms race happening at the microscopic level inside us right now.

As their factories continuously upgrade their defenses,

our ability to design the next structural lock and key determines who wins the race.

That is an incredibly sobering, yet totally fascinating reality of modern medicine.

Well, on behalf of the entire Last Minute Lecture team, thank you so much for joining us on this deep dive.

We hope this conceptual map of the bacterial ribosome helps you master the mechanisms, and we wish you the absolute best of luck on your upcoming exams and your future clinical practice.

Keep the logic of the factory in your head, and you'll do great.